Skip to main content
. 2018 Nov 13;9:1279. doi: 10.3389/fphar.2018.01279

Figure 1.

Figure 1

Cutaneous leukemic skin infiltrates: Skin lesions on the face (A,C,E) and the back of the left upper arm (B,D,F) are shown. Panels (A,B) represent the treatment-naive state. Panels (C,D) show the lesions after one cycle of azacitidine and one cycle of combined biomodulatory therapy. Panels (E,F) demonstrate complete remission of skin lesions after six cycles of biomodulatory treatment.